BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31152306)

  • 1. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
    Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
    Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated radiotherapy versus conventional radiotherapy in early glottic cancer T1-2N0M0: A randomized study.
    Kachhwaha A; Jakhar SL; Syiem T; Sharma N; Kumar HS; Sharma A
    J Cancer Res Ther; 2021; 17(6):1499-1502. PubMed ID: 34916384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
    Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer.
    Kim KN; Dyer MA; Qureshi MM; Shah NK; Grillone GA; Faden DL; Jalisi SM; Truong MT
    Am J Otolaryngol; 2020; 41(5):102544. PubMed ID: 32505989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.
    Mucha-Małecka A; Chrostowska A; Urbanek K; Małecki K
    Strahlenther Onkol; 2019 Sep; 195(9):792-804. PubMed ID: 31214734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.
    Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Hirakawa A; Naganawa S
    Asian Pac J Cancer Prev; 2018 May; 19(5):1195-1199. PubMed ID: 29801401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1-2 glottic cancer treated with radiotherapy and/or surgery.
    Shelan M; Anschuetz L; Schubert AD; Bojaxhiu B; Dal Pra A; Behrensmeier F; Aebersold DM; Giger R; Elicin O
    Strahlenther Onkol; 2017 Dec; 193(12):995-1004. PubMed ID: 28474090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.
    Cacicedo J; Casquero F; del Hoyo O; Gomez-Iturriaga A; Martinez-Indart L; Lopez JL; Bilbao P
    Clin Transl Oncol; 2013 Nov; 15(11):925-31. PubMed ID: 23519536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
    Janssen S; Glanzmann C; Huber G; Studer G
    Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
    Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional fractionation should not be the standard of care for T2 glottic cancer.
    Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
    Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy.
    Mucha-Małecka A; Małecki K; Amrogowicz N; Biesaga B; Modrzejewski M
    Sci Rep; 2021 Sep; 11(1):17717. PubMed ID: 34489495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
    Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
    Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
    Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1014-1021. PubMed ID: 28721883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy in glottic T1 carcinoma. Local control and survival].
    Herranz J; Fernández M; Ramos S; Vázquez Barro C; Sarandeses García A; Martínez Vidal J; Veiras C
    Acta Otorrinolaringol Esp; 2000; 51(1):57-61. PubMed ID: 10799934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
    Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.